These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17119931)

  • 1. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.
    Metzger KL; Shoemaker JM; Kahn JB; Maxwell CR; Liang Y; Tokarczyk J; Kanes SJ; Hans M; Lowman AM; Dan N; Winey KI; Swerdlow NR; Siegel SJ
    Psychopharmacology (Berl); 2007 Feb; 190(2):201-11. PubMed ID: 17119931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo demonstration of risperidone implants in mice.
    Rabin C; Liang Y; Ehrlichman RS; Budhian A; Metzger KL; Majewski-Tiedeken C; Winey KI; Siegel SJ
    Schizophr Res; 2008 Jan; 98(1-3):66-78. PubMed ID: 17765477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia.
    Siegel SJ; Winey KI; Gur RE; Lenox RH; Bilker WB; Ikeda D; Gandhi N; Zhang WX
    Neuropsychopharmacology; 2002 Jun; 26(6):817-23. PubMed ID: 12007752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits.
    Martinez ZA; Oostwegel J; Geyer MA; Ellison GD; Swerdlow NR
    Neuropsychopharmacology; 2000 Nov; 23(5):517-27. PubMed ID: 11027917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment.
    Russig H; Spooren W; Durkin S; Feldon J; Yee BK
    Psychopharmacology (Berl); 2004 Sep; 175(2):143-7. PubMed ID: 14985922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
    Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
    Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Wunderink YS; Ellenbroek BA; Cools AR
    Psychopharmacology (Berl); 2007 Jan; 190(1):93-102. PubMed ID: 17031706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity.
    Yee BK; Russig H; Feldon J
    Neuropsychopharmacology; 2004 Feb; 29(2):240-8. PubMed ID: 14666120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
    J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats.
    Bortolato M; Aru GN; Frau R; Orrù M; Fà M; Manunta M; Puddu M; Mereu G; Gessa GL
    Biol Psychiatry; 2005 Jun; 57(12):1550-8. PubMed ID: 15953492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
    Linn GS; Negi SS; Gerum SV; Javitt DC
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis.
    Feifel D; Reza T; Robeck S
    Neuropsychopharmacology; 1999 Feb; 20(2):141-9. PubMed ID: 9885794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Startle and sensorimotor gating in rats lacking CCK-A receptors.
    Feifel D; Priebe K; Shilling PD
    Neuropsychopharmacology; 2001 Jun; 24(6):663-70. PubMed ID: 11331146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains.
    Zarate JM; Boksa P; Baptista T; Joober R
    Psychopharmacology (Berl); 2004 Jan; 171(2):162-72. PubMed ID: 14615871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic dosing and drug delivery.
    Rabin CR; Siegel SJ
    Curr Top Behav Neurosci; 2010; 4():141-77. PubMed ID: 21312400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs.
    Dirks A; Groenink L; Westphal KG; Olivier JD; Verdouw PM; van der Gugten J; Geyer MA; Olivier B
    Neuropsychopharmacology; 2003 Oct; 28(10):1790-8. PubMed ID: 12865891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia.
    Amann LC; Gandal MJ; Lin R; Liang Y; Siegel SJ
    Pharm Res; 2010 Aug; 27(8):1730-7. PubMed ID: 20422263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
    Duncan GE; Moy SS; Lieberman JA; Koller BH
    Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
    Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
    Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.